Therapeutic Asset Ratings
3,171 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
IM19 CAR-T cells
Leukemia
Beijing Immunochina Medical Science & Technology Co., Ltd.
P1/2
CC
(46)
Obx-115
Melanoma
Obsidian Therapeutics, Inc.
P1/2
CC
(46)
TIL
Glioblastoma
Essen Biotech
P1/2
CC
(46)
Tumor-Draining Lymph Node-Derived Lymphocyte
Breast Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P1/2
CC
(46)
Dilanubicel
Acute Lymphoblastic Leukemia
Fred Hutchinson Cancer Center
P2
CC
(45)
BIOTINYLATED HUMAN RED BLOOD CELL
Sickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI)
P1
CC
(45)
a2b543
Mesothelioma
A2 Biotherapeutics Inc.
P1/2
CC
(45)
a2b543
Malignant Mesothelioma
A2 Biotherapeutics Inc.
P1/2
CC
(45)
a2b543
Pancreatic Neoplasm
A2 Biotherapeutics Inc.
P1/2
CC
(45)
a2b694
Mesothelioma
A2 Biotherapeutics Inc.
P1/2
CC
(45)
a2b694
Malignant Mesothelioma
A2 Biotherapeutics Inc.
P1/2
CC
(45)
a2b694
Pancreatic Neoplasm
A2 Biotherapeutics Inc.
P1/2
CC
(45)
Allogeneic Adipose-Derived Mesenchymal Stem Cells
Erectile Dysfunction
The Methodist Hospital Research Institute
P1/2
CC
(45)
Allogeneic Cytomegalovirus-Specific T Cells
Glioblastoma
Queensland Institute of Medical Research
P1/2
CC
(45)
ALLOGENEIC HUMAN UMBILICAL CORD BLOOD
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
The First Affiliated Hospital with Nanjing Medical University
P1/2
CC
(45)
Anti-Cd33 Car-Nk Cells
Acute Myeloid Leukemia
Nationwide Children's Hospital
P1/2
CC
(45)
Anti-Cll1 Cart Cells
Acute Myeloid Leukemia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
P1/2
CC
(45)
Anti-Kras G12V Mtcr Pbl
Digestive System Cancer
National Cancer Institute (NCI)
P1/2
CC
(45)
Anti-Steap1 Car T-Cells
Prostate Adenocarcinoma
Fred Hutchinson Cancer Center
P1/2
CC
(45)
at101
B-Cell Non-Hodgkin Lymphoma
AbClon
P1/2
CC
(45)
Autologous Bcma/Cd19 Dual-Target Car-T Module
T-Cell Acute Lymphoblastic Leukemia
Beijing Biotech
P1/2
CC
(45)
Autologous Bcma/Cd19 Dual-Target Car-T Module
T-Lymphoblastic Lymphoma
Beijing Biotech
P1/2
CC
(45)
Autologous Bcma/Cd38 Dual-Target Car-T Module
T-Cell Acute Lymphoblastic Leukemia
Beijing Biotech
P1/2
CC
(45)
Autologous Bcma/Cd38 Dual-Target Car-T Module
T-Lymphoblastic Lymphoma
Beijing Biotech
P1/2
CC
(45)
Autologous Bcma/Gprc5D Dual-Target Car-T
T-Cell Acute Lymphoblastic Leukemia
Beijing Biotech
P1/2
CC
(45)
Showing 851 to 875 of 3,171 assets
Previous
Page 35 of 127
Next
